These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 8865880

  • 21. Continuous ambulatory peritoneal dialysis in children: comparison with hemodialysis.
    Baum M, Powell D, Calvin S, McDaid T, McHenry K, Mar H, Potter D.
    N Engl J Med; 1982 Dec 16; 307(25):1537-42. PubMed ID: 6815528
    [Abstract] [Full Text] [Related]

  • 22. Continuous ambulatory peritoneal dialysis (CAPD) on Merseyside--cost/cost effectiveness.
    Beardsworth SF, Goldsmith HJ.
    Health Trends; 1982 Nov 16; 14(4):89-92. PubMed ID: 10309841
    [Abstract] [Full Text] [Related]

  • 23. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N, Guest S, Wong L, Inglese G, Bhattacharyya SK, Gehr T, Walker DR, Golper T.
    Clin Ther; 2009 Apr 16; 31(4):880-8. PubMed ID: 19446160
    [Abstract] [Full Text] [Related]

  • 24. Cost analysis of dialysis modalities in Italy.
    Tediosi F, Bertolini G, Parazzini F, Mecca G, Garattini L.
    Health Serv Manage Res; 2001 Feb 16; 14(1):9-17. PubMed ID: 11246787
    [Abstract] [Full Text] [Related]

  • 25. Designing dialysis prescriptions.
    Manuel A, Gray B, Coulis N, Brunier G, Desson F, Paton MA, Tobe S.
    Adv Perit Dial; 1996 Feb 16; 12():136-42. PubMed ID: 8865888
    [Abstract] [Full Text] [Related]

  • 26. [Costs of care in uremia. How much does kidney transplantation cost?].
    Jakobsen A, Albrechtsen D, Sødal G, Flatmark A, Fauchald P, Vartdal F.
    Tidsskr Nor Laegeforen; 1990 Jan 30; 110(3):338-41. PubMed ID: 2309175
    [Abstract] [Full Text] [Related]

  • 27. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA, Ishola DA, Sanusi AA, Akinsola A.
    Afr J Med Med Sci; 2005 Sep 30; 34(3):227-33. PubMed ID: 16749353
    [Abstract] [Full Text] [Related]

  • 28. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K.
    Nephrol Dial Transplant; 2008 Jun 30; 23(6):1982-9. PubMed ID: 18174268
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hospitalizations in patients treated sequentially by chronic hemodialysis and continuous peritoneal dialysis.
    Adeniyi M, Kassam H, Agaba EI, Sun Y, Servilla KS, Raj DS, Murata GH, Tzamaloukas AH.
    Adv Perit Dial; 2009 Jun 30; 25():72-5. PubMed ID: 19886321
    [Abstract] [Full Text] [Related]

  • 31. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
    Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F, Sánchez Tomero JA, Selgas R.
    Nefrologia; 2011 Jun 30; 31(5):505-13. PubMed ID: 21959716
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 Jun 30; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 34. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF, Dratwa M, Wiedemann ME.
    Nephrol Dial Transplant; 1999 Jun 30; 14 Suppl 6():31-41. PubMed ID: 10528710
    [Abstract] [Full Text] [Related]

  • 35. Angio and peritoneal access for endstage renal disease in the community hospital: a cost analysis.
    Chapman JE, Sinicrope RA, Clark DM.
    Am Surg; 1986 Jun 30; 52(6):315-9. PubMed ID: 3717777
    [Abstract] [Full Text] [Related]

  • 36. Outcome and survival in different peritoneal dialysis modalities.
    Al-Hilali N, Al-Humoud H, Nampoory M, Ninan A, Johny K.
    Ther Apher Dial; 2007 Apr 30; 11(2):101-6. PubMed ID: 17381530
    [Abstract] [Full Text] [Related]

  • 37. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA, del Peso G, Jiménez V, Aguilera A, Villar A, Jiménez C, Selgas R.
    Adv Perit Dial; 2000 Apr 30; 16():170-3. PubMed ID: 11045286
    [Abstract] [Full Text] [Related]

  • 38. Home dialysis: its costs and problems.
    Rae A, Craig P, Miles G.
    Can Med Assoc J; 1972 Jun 24; 106(12):1305 passim. PubMed ID: 5035137
    [Abstract] [Full Text] [Related]

  • 39. Cost of Dialysis Therapy by Modality in Manitoba.
    Beaudry A, Ferguson TW, Rigatto C, Tangri N, Dumanski S, Komenda P.
    Clin J Am Soc Nephrol; 2018 Aug 07; 13(8):1197-1203. PubMed ID: 30021819
    [Abstract] [Full Text] [Related]

  • 40. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I.
    Transplant Proc; 1992 Feb 07; 24(1):335. PubMed ID: 1539301
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.